A sample can be sterile and still contain endotoxin. Routine steam sterilization can kill bacteria while leaving these Gram-negative bacterial components behind. A sterility test doesn’t measure endotoxin.
https://t.co/BTh1cMW3dv
CBL-514 is designed to trigger apoptosis: programmed death of fat cells.
The proposed pathway starts with inhibiting DYRK1B. That shifts the balance toward Bax, which promotes cell death, and away from Bcl-2, which supports survival. Caspase-3 then helps dismantle the cell.
https://t.co/vW0dtA1210
@oasishealthapp The photo shows a 15 mg/dose pen; the results graphic says 2.5 mg. For the 2.5 mg version, 10.27 mg per 2.4 mL corresponds to 102.7% of label claim.
Take two 10 mg powder samples, both 99% HPLC purity.
Using Bachem’s calculation, 80% net peptide content gives ~7.92 mg of target peptide; 90% gives ~8.91 mg.
Water and counterions add weight without appearing in that purity percentage.
https://t.co/4a95h3dQSc
Josh’s 10 reported results span 108.6–138.6% of label claim. A one-vial result could have made this order look very different, depending on which vial was picked.
I know someone asked for the raw assay values that went into content uniformity:
132.16%
133.22%
108.60%
132.23%
134.40%
134.58%
134.61%
138.63%
135.30%
132.33%
Based on this data, the 108 looks like a special cause (although not that special since the vial used for the assay result was 107%)
Trying to get quantities locked before we send samples for testing. Otherwise you can get the report back and find there isn’t enough stock left from that batch.
@PioneerPeptides@researchitgg Do you have a redacted example of how you’d show the unidentified peaks on a report? Would be useful to see what the buyer actually gets.
Same 3 mL vial. Completely different job getting there.
BPC-157 is a relatively short synthetic peptide. GHK-Cu adds metal complexation. Semaglutide, tirzepatide and retatrutide bring longer sequences, modifications and more demanding purification. HGH isn’t even made the same way. it’s a recombinant protein.
I’ve spent an unreasonable amount of time clarifying what someone means by “pen”. Empty device, filled cartridge, dual chamber, liquid, disposable/reusable. We’ve discussed prices before realizing we were talking about different products.
CBL-514 is crazy
Phase 2b: ~20% mean reduction in abdominal fat volume by MRI, and 76.7% of treated patients improved by at least one clinical grade vs 18.9% placebo. Most responders saw improvement after only 1–2 treatments.
We’ve got CBL-514 in stock now.